Cerebral venous sinus thrombosis

Abstract

Cerebral venous sinus thrombosis (CVST) is a relatively uncommon but important cause of stroke-like disease, accounting for fewer than 1% of all strokes. CVST is more common in females and infants. CVST patients are most common in the third decade, with a female-to-male ratio of 5:1.5. The incidence of CVST has been found to be high in developing countries, particularly in South-East Asia. Headache is the most prevalent clinical sign of CVST, occurring in 88% to 93% of patients, followed by a seizure in 37% to 71%, focal neurological deficit in 20% to 54%, and isolated increased intracranial pressure in 23%.[1] A 34-year-old male came to the tertiary care hospital with complaints of headache, vomiting, and vertigo for 1 day. Headache is insidious, progressive, nonradiating, holocephalic, severe in intensity and associated with vertigo and dizziness, and giddiness, he also complained about nausea and vomiting (10–12 episodes/day) containing food and water. The patient had no family history but has been chronic tobacco chewer for 10 years. Past medical history revealed that he was admitted to the hospital before for the same complaints and he also had right lower vein deep-vein thrombosis 6 months back. His magnetic imaging resonance reports and protein S and C deficiency reports revealed that he was suffering from CVST. He was prescribed with anticoagulants and other supportive treatments that include antiemetic, analgesics, and multivitamins, which cause faster and better recovery of patients.

Keywords

• anticoagulants
• cerebral venous sinus thrombosis
• magnetic resonance imaging
• protein c
• protein s
• stroke